The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in income, its intellectual property lapse created a deluge of knock-off medications, significantly eroding its market share . While some firms may attempt to capitalize on male sexual dysfunction, the web